Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Gillery

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Clinical Chemistry and Laboratory Medicine|September 8, 2023
Biological management of diabetes mellitus, the laboratory medicine specialist and the patientPhilippe Gillery
Clinical Chemistry and Laboratory Medicine|June 3, 2015
New trends in the long and puzzling history of HbA1cPhilippe Gillery
Clinical Chemistry and Laboratory Medicine|October 14, 2022
HbA<sub>1c</sub> and biomarkers of diabetes mellitus in <i>Clinical Chemistry and Laboratory Medicine</i>: ten years afterPhilippe Gillery
Annales De Biologie Clinique|July 25, 2012
[Sign of the times]Philippe Gillery
Clinical Chemistry and Laboratory Medicine|November 23, 2018
The long way to standardization of practices: HbA1c as archetypal examplePhilippe Gillery
Clinical Chemistry and Laboratory Medicine|September 21, 2012
A history of HbA1c through Clinical Chemistry and Laboratory MedicinePhilippe Gillery
Clinical Chemistry and Laboratory Medicine|June 16, 2018
Innovative approaches in diabetes diagnosis and monitoring: less invasive, less expensive… but less, equally or more efficient?Stéphane Jaisson, Philippe Gillery
Clinical Chemistry|June 22, 2010
Evaluation of nonenzymatic posttranslational modification-derived products as biomarkers of molecular aging of proteinsStéphane Jaisson, Philippe Gillery
Journal of Proteomics|March 6, 2013
Usefulness of non-enzymatic post-translational modification derived products (PTMDPs) as biomarkers of chronic diseasesPhilippe Gillery, Stéphane Jaisson
Diabetologia|May 13, 2014
Impaired proteostasis: role in the pathogenesis of diabetes mellitusStéphane Jaisson, Philippe Gillery
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Clinical Chemistry and Laboratory Medicine|September 8, 2023
Biological management of diabetes mellitus, the laboratory medicine specialist and the patientPhilippe Gillery
Clinical Chemistry and Laboratory Medicine|June 3, 2015
New trends in the long and puzzling history of HbA1cPhilippe Gillery
Clinical Chemistry and Laboratory Medicine|October 14, 2022
HbA<sub>1c</sub> and biomarkers of diabetes mellitus in <i>Clinical Chemistry and Laboratory Medicine</i>: ten years afterPhilippe Gillery
Annales De Biologie Clinique|July 25, 2012
[Sign of the times]Philippe Gillery
Clinical Chemistry and Laboratory Medicine|November 23, 2018
The long way to standardization of practices: HbA1c as archetypal examplePhilippe Gillery
Clinical Chemistry and Laboratory Medicine|September 21, 2012
A history of HbA1c through Clinical Chemistry and Laboratory MedicinePhilippe Gillery
Clinical Chemistry and Laboratory Medicine|June 16, 2018
Innovative approaches in diabetes diagnosis and monitoring: less invasive, less expensive… but less, equally or more efficient?Stéphane Jaisson, Philippe Gillery
Clinical Chemistry|June 22, 2010
Evaluation of nonenzymatic posttranslational modification-derived products as biomarkers of molecular aging of proteinsStéphane Jaisson, Philippe Gillery
Journal of Proteomics|March 6, 2013
Usefulness of non-enzymatic post-translational modification derived products (PTMDPs) as biomarkers of chronic diseasesPhilippe Gillery, Stéphane Jaisson
Diabetologia|May 13, 2014
Impaired proteostasis: role in the pathogenesis of diabetes mellitusStéphane Jaisson, Philippe Gillery
Pageof 13